Literature DB >> 8508942

An adverse reaction following sialography.

D J Cockrell1, P G Rout.   

Abstract

Reactions following the administration of iodine are well documented in general radiography, but are unusual following sialography. A patient who experienced an adverse reaction following sialography with an iodine-based, low osmolar, contrast medium, Hexabrix 320, is presented. The reaction consisted of severe shoulder and back pain 24 h after the procedure. A skin rash was identified involving the right axilla, groin and elbow, with swelling visible around the right elbow joint. It was not possible to distinguish, on the basis of the available evidence, between an anaphylactoid and idiosyncratic allergic reaction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8508942     DOI: 10.1259/dmfr.22.1.8508942

Source DB:  PubMed          Journal:  Dentomaxillofac Radiol        ISSN: 0250-832X            Impact factor:   2.419


  4 in total

1.  Comparative study of MR sialography and digital subtraction sialography for benign salivary gland disorders.

Authors:  Marc Kalinowski; Johannes T Heverhagen; Elisabeth Rehberg; Klaus Jochen Klose; Hans-Joachim Wagner
Journal:  AJNR Am J Neuroradiol       Date:  2002-10       Impact factor: 3.825

Review 2.  Modern management of obstructive salivary diseases.

Authors:  P Capaccio; S Torretta; F Ottavian; G Sambataro; L Pignataro
Journal:  Acta Otorhinolaryngol Ital       Date:  2007-08       Impact factor: 2.124

3.  Evaluation of volumetric measurements on CBCT images using stafne bone cavities as an example.

Authors:  Mehmet-Zahit Adisen; Selmi Yilmaz; Melda Misirlioglu; Fethi Atil
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-09-01

4.  Imaging Activated-T-Lymphocytes in the Salivary Glands of Patients with Sjögren's Syndrome by 99mTc-Interleukin-2: Diagnostic and Therapeutic Implications.

Authors:  Giuseppe Campagna; Luz Kelly Anzola; Michela Varani; Chiara Lauri; Guido Gentiloni Silveri; Lorenzo Chiurchioni; Francesca Romana Spinelli; Roberta Priori; Fabrizio Conti; Alberto Signore
Journal:  J Clin Med       Date:  2022-07-27       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.